Sysmex Corporation (6869) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Sysmex Corporation (6869:JPX), powered by AI.

Current Price
¥1,421.5
P/E Ratio
16.5
Market Cap
886.4B
Sector
Healthcare
What is the Sysmex Corporation stock price forecast?

Sysmex Corporation is currently trading at ¥1,421.5. View real-time AI analysis on Alpha Lenz.

What is Sysmex Corporation insider trading activity?

View the latest insider trading data for Sysmex Corporation on Alpha Lenz.

What is Sysmex Corporation's P/E ratio?

Sysmex Corporation's P/E ratio is 16.5.

Sysmex Corporation

JPX · 6869
¥1,422+16(+1.14%)Market closedJPX regular session 09:00–15:00 JST
Ask about Sysmex Corporation's future dividend policy...
Alpha Chat Insight

Sysmex Corporation trades at a P/E of 16.5 (fair value) with solid ROE of 12.0%. 3Y revenue CAGR of 11.8% highlights clear growth momentum.

Ask for details

Company Overview

Sysmex Corporation is a global leader in the design, development, and distribution of diagnostic testing systems and healthcare-related products. Headquartered in Kobe, Japan, Sysmex offers a comprehensive range of laboratory diagnostics equipment used in clinical settings, from hematology analyzers to urinalysis systems. These systems streamline processes in medical laboratories by automating and enhancing the accuracy and efficiency of blood and fluid testing. Widely employed across hospitals, clinics, and research institutions, Sysmex’s solutions are integral in facilitating early diagnosis and monitoring of diseases, thereby playing a crucial role in patient care and management. The company’s influence extends across various sectors, primarily impacting healthcare, biotechnology, and medical research industries. With a strong emphasis on innovation and technology, Sysmex also supports laboratory automation and information systems, making it a pivotal entity in the evolving landscape of personalized medicine. Known for its robust R&D initiatives, Sysmex contributes significantly to advancements in medical diagnostics, maintaining a reputable position within the global healthcare market through its dedication to improving health outcomes.

CEOMr. Hisashi Ietsugu
SectorHealthcare
IndustryMedical Devices
Employees10,533

Company Statistics

FY 2025

Profile

¥886,377,175,057Market Cap
¥508,643,000,000Revenue
0.00Shares Out
10,533Employees

Margins

53.47%Gross
24.57%EBITDA
17.85%Operating
15.57%Pre-Tax
10.53%Net

Valuation

16.52P/E
1.91P/B
1.74EV/Sales
6.90EV/EBITDA
23.15P/FCF

Growth (CAGR)

11.82%Rev 3Yr
10.99%Rev 5Yr
10.43%Op Inc 3Yr
10.43%Op Inc 5Yr
6.73%Net Inc 3Yr
9.00%Net Inc 5Yr

Returns

8.34%ROA
11.98%ROE
12.89%ROIC

Financial Health

¥89,570,000,000Cash & Cash Equivalents
¥111,164,000,000Net Debt
43.21%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Sysmex Corporation (ticker: 6869) is a company listed on JPX in the Healthcare sector (Medical Devices). It has approximately 10,533 employees. Market cap is $886.4B.

The current price is 1,421.5 with a P/E ratio of 16.52x and P/B of 1.91x.

ROE is 11.98% and operating margin is 17.85%. Annual revenue is $508.6B.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Sysmex Corporation (6869) Stock Forecast 2026 ¥1,421.5 — Price, Financials & Analyst Targets | Alpha Lenz